genome-wide association study identifies novel breast cancer susceptibility loci 
breast cancer exhibits familial aggregation consistent variation genetic susceptibility disease known susceptibility genes account less % familial risk breast cancer residual genetic variance likely due variants conferring moderate risks identify susceptibility alleles conducted two-stage genome-wide association study breast cancer cases controls followed third stage single nucleotide polymorphisms snps tested confirmation cases controls studies used snps estimated correlate % known common snps europeans r2 > snps five novel independent loci exhibited strong consistent evidence association breast cancer p < - four contain plausible causative genes fgfr2 tnrc9 map3k1 lsp1 second stage snps significant p < level compared estimated expected chance indicating many additional common susceptibility alleles may identifiable approach 
